In partnership with…

A new category of  insurance for a new generation ​of cancer management

CancerŌme provides policyholders with an extensive suite of unique prevention, management, and recovery benefits in addition to structured cash payouts.

A first of its kind, patent pending, disease-specific, ōmics-based insurance policy.

Cancer Prevention

Proactive Genetic Screening
Genetic Counseling
Action Plan
Cancer Management
Comprehensive Genomic Profiling
Propriatory Precision Support & Navigation Services
Financial Protection
Cash Payouts (3 x per claim)
Cancer Recovery
Propriatory molecular monitoring service created specifically to detect early signs of cancer recurrence.

Ōmics…​ a Primer


Genomics is the study of all of a person’s genes (the genome), including interactions of those genes with each other and with the person’s environment
The study of all of the epigenetic changes in a cell. Epigenetic changes are changes in the way genes are switched on and off without changing the actual DNA sequence. They may be caused by age and exposure to environmental factors, such as diet, exercise, drugs, and chemicals.
The study of all RNA molecules in a cell. RNA is copied from pieces of DNA and contains information to make proteins and perform other important functions in the cell. Transcriptomics is used to learn more about how genes are turned on in different types of cells and how this may help cause certain diseases, such as cancer.
The study of the structure and function of proteins, including the way they work and interact with each other inside cells.
The study of all the chemical changes that take place in a cell or an organism. These changes make energy and the materials cells and organisms need to grow, reproduce, and stay healthy. Metabolism also helps get rid of toxic substances.

The Standard of Care is 17 years behind the health technology curve. We can do so much better – we must do better! 1

1  Institute of Medicine. 2001.  Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: The National Academies Press.

Ōmics is at the heart of precision or personalized medicine and refers to different approaches to better understand disease prevention and management.
We’ve built a world-class, integrated ecosystem of ōmics technologies and expertise to create plug-and-play [white-labeled] insurance products that improve policyholder engagement, satisfaction, health outcomes, and increase carrier revenue.

Did You

Fewer than one in five individuals with a history of breast or ovarian cancer who meet national genetics testing recommendation guidelines have undergone genetic testing (1).

1. ​Childers, CP et al. National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer. J Clin Oncol. 2017

Oncology has been a major focus for genomic technologists and the utility of genomics in oncology is easily defined. Genomics and precision medicine can dramatically improve mortality rates(2).

2. Tsimberidou, AM et al. Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine. J Hematol Oncol. 2019